These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3108992)

  • 21. Infectivity of blood seropositive for hepatitis C virus antibodies.
    van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN
    Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.
    Aach RD; Szmuness W; Mosley JW; Hollinger FB; Kahn RA; Stevens CE; Edwards VM; Werch J
    N Engl J Med; 1981 Apr; 304(17):989-94. PubMed ID: 6782484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The usefulness of surrogate markers anti-HBc and ALT for post-transfusion non-A, non-B hepatitis prevention.
    Richard D
    J Virol Methods; 1987 Aug; 17(1-2):105-17. PubMed ID: 3117828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes.
    Mosley JW; Huang W; Stram DO; Nowicki MJ; Hollinger FB; Aach RD; Stevens CE; Barbosa LH; Nemo GJ
    Transfusion; 1996 Sep; 36(9):776-81. PubMed ID: 8823449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transfusion hepatitis revisited.
    Ismay SL; Thomas S; Fellows A; Keller A; Kenrick KG; Archer GT; Wylie BR; Cossart YE
    Med J Aust; 1995 Jul; 163(2):74-7. PubMed ID: 7542359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of routine anti-HBc screening of volunteer blood donors: a questionable surrogate test for non-A, non-B hepatitis.
    Hanson MR; Polesky HF
    Transfusion; 1987; 27(1):107-8. PubMed ID: 3101245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. A prospective study in Finland.
    Ebeling F
    Vox Sang; 1991; 60(4):219-24. PubMed ID: 1681620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum levels of alanine aminotransferase and anti-HBc antibodies in blood donors: analysis of a group of 5000 donors from the Lorraine region].
    Janot C; Aymard JP; Petegnief P; Schooneman F; Legras B; Monange G; Streiff F
    Rev Fr Transfus Hemobiol; 1989 Feb; 32(1):69-72. PubMed ID: 2719779
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevalence of antibodies to hepatitis C (anti HCV) in blood donors in Rio de Janeiro, Brazil. Its relation to ALT and anti HBC].
    Leite NC; Nogueira CM; Coelho HS; Perez R; Martins SJ; Soares JA; Junqueira PC
    Arq Gastroenterol; 1992; 29(1):5-11. PubMed ID: 1307202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
    Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
    Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for the prevention of post-transfusion hepatitis.
    Mintz PD
    Ann Clin Lab Sci; 1984; 14(3):198-207. PubMed ID: 6428295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
    Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
    Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study.
    Colin C; Vergnon P; Jullien AM; Excoffier S; Matillon Y; Trepo C
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):220-7. PubMed ID: 9131325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum bile acids and alanine aminotransferase concentrations. Comparison of efficacy as indirect means of identifying carriers of non-A, non-B hepatitis agents and of onset, severity, and duration of posttransfusion non-A, non-B hepatitis in recipients.
    Mishler JM; Barbosa L; Mihalko LJ; McCarter H
    JAMA; 1981 Nov; 246(20):2340-4. PubMed ID: 6795368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group.
    Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective controlled study of post-transfusion hepatitis after cardiac surgery in a large referral hospital in India.
    Dasarathy S; Misra SC; Acharya SK; Irshad M; Joshi YK; Venugopal P; Tandon BN
    Liver; 1992 Jun; 12(3):116-20. PubMed ID: 1323739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive study of the safety of using anti-hepatitis B core (Hbc) positive subjects in living donor liver transplants.
    Lei J; Yan L; Wang W
    Hepatogastroenterology; 2013 Sep; 60(126):1426-32. PubMed ID: 23933935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.